FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. purchased 54.7% of their position (3.60M shares) of BRAVEHEART BIO, INC. on the open market
Open‑market purchase worth $64.80M — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+9.13M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+7.99M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.92M
Price / share
$18.00
Trade value
$34.56M
% of position
Common Stock
Shares
+1.68M
Price / share
$18.00
Trade value
$30.24M
% of position
Net shares
+20.72M
Net value
$64.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/7/2026 | C · Conversion | +9.13M | — | — | 1552.8% | 588.13K | 9.72M |
| Common Stock Indirect | 8/7/2026 | C · Conversion | +7.99M | — | — | 1552.8% | 514.61K | 8.51M |
| Common Stock Direct | 8/7/2026 | P · Purchase | +1.92M | $18.00 | $34.56M | 19.8% | 9.72M | 11.64M |
| Common Stock Indirect | 8/7/2026 | P · Purchase | +1.68M | $18.00 | $30.24M | 19.8% | 8.51M | 10.19M |
| Total | +20.72M | $64.80M | ||||||
Series A Preferred Stock
Common Stock
9.13M shares
Shares
−40M
Strike price
Held after
0.00
Exercisable
—
Series A Preferred Stock
Common Stock
7.99M shares
Shares
−35M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock9.13M shares | 8/7/2026 | C · Conversion | −40M | — | 0.00 | |
| Series A Preferred Stock Indirect | Common Stock7.99M shares | 8/7/2026 | C · Conversion | −35M | — | 0.00 |